{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:30:09Z","timestamp":1773289809056,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It has been suggested that miR-144 is pro-atherosclerotic via effects on reverse cholesterol transportation targeting the ATP binding cassette protein. This study used proteomic analysis to identify additional cardiovascular targets of miR-144, and subsequently examined the role of a newly identified regulator of atherosclerotic burden in miR-144 knockout mice receiving a high fat diet. To identify affected secretory proteins, miR-144 treated endothelial cell culture medium was subjected to proteomic analysis including two-dimensional gel separation, trypsin digestion, and nanospray liquid chromatography coupled to tandem mass spectrometry. We identified 5 gel spots representing 19 proteins that changed consistently across the biological replicates. One of these spots, was identified as vimentin. Atherosclerosis was induced in miR-144 knockout mice by high fat diet and vascular lesions were quantified by Oil Red-O staining of the serial sectioned aortic root and from en-face views of the aortic tree. Unexpectedly, high fat diet induced extensive atherosclerosis in miR-144 knockout mice and was accompanied by severe fatty liver disease compared with wild type littermates. Vimentin levels were reduced by miR-144 and increased by antagomiR-144 in cultured cardiac endothelial cells. Compared with wild type, ablation of the miR-144\/451 cluster increased plasma vimentin, while vimentin levels were decreased in control mice injected with synthetic miR-144. Furthermore, increased vimentin expression was prominent in the commissural regions of the aortic root which are highly susceptible to atherosclerotic plaque formation. We conclude that miR-144 maybe a potential regulator of the development of atherosclerosis via changes in vimentin signaling.<\/jats:p>","DOI":"10.1038\/s41598-020-63335-7","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T10:03:56Z","timestamp":1586426636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation"],"prefix":"10.1038","volume":"10","author":[{"given":"Quan","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Greis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew N.","family":"Redington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"63335_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","volume":"46","author":"S Barquera","year":"2015","unstructured":"Barquera, S. et al. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res 46, 328\u2013338, https:\/\/doi.org\/10.1016\/j.arcmed.2015.06.006 (2015).","journal-title":"Arch Med Res"},{"key":"63335_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38, 2459\u20132472, https:\/\/doi.org\/10.1093\/eurheartj\/ehx144 (2017).","journal-title":"Eur Heart J"},{"key":"63335_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","volume":"129","author":"S Allahverdian","year":"2014","unstructured":"Allahverdian, S., Chehroudi, A. C., McManus, B. M., Abraham, T. & Francis, G. A. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129, 1551\u20131559, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005015 (2014).","journal-title":"Circulation"},{"key":"63335_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood-2016-07-692673","volume":"129","author":"MD Wu","year":"2017","unstructured":"Wu, M. D., Atkinson, T. M. & Lindner, J. R. Platelets and von Willebrand factor in atherogenesis. Blood 129, 1415\u20131419, https:\/\/doi.org\/10.1182\/blood-2016-07-692673 (2017).","journal-title":"Blood"},{"key":"63335_CR5","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1161\/STROKEAHA.118.022888","volume":"49","author":"TA Fasipe","year":"2018","unstructured":"Fasipe, T. A. et al. Extracellular Vimentin\/VWF (von Willebrand Factor) Interaction Contributes to VWF String Formation and Stroke Pathology. Stroke 49, 2536\u20132540, https:\/\/doi.org\/10.1161\/STROKEAHA.118.022888 (2018).","journal-title":"Stroke"},{"key":"63335_CR6","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1182\/blood-2013-10-530428","volume":"123","author":"Q Da","year":"2014","unstructured":"Da, Q., Behymer, M., Correa, J. I., Vijayan, K. V. & Cruz, M. A. Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress. Blood 123, 2715\u20132721, https:\/\/doi.org\/10.1182\/blood-2013-10-530428 (2014).","journal-title":"Blood"},{"key":"63335_CR7","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1161\/ATVBAHA.118.310227","volume":"38","author":"Y Lu","year":"2018","unstructured":"Lu, Y., Thavarajah, T., Gu, W., Cai, J. & Xu, Q. Impact of miRNA in Atherosclerosis. Arterioscler Thromb Vasc Biol 38, e159\u2013e170, https:\/\/doi.org\/10.1161\/ATVBAHA.118.310227 (2018).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"63335_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/ATVBAHA.114.304878","volume":"35","author":"S Meiler","year":"2015","unstructured":"Meiler, S., Baumer, Y., Toulmin, E., Seng, K. & Boisvert, W. A. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol 35, 323\u2013331, https:\/\/doi.org\/10.1161\/ATVBAHA.114.304878 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"63335_CR9","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","volume":"112","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim, T. Q. et al. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ Res 112, 1602\u20131612, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300648 (2013).","journal-title":"Circ Res"},{"key":"63335_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","volume":"112","author":"CM Ramirez","year":"2013","unstructured":"Ramirez, C. M. et al. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res 112, 1592\u20131601, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300626 (2013).","journal-title":"Circ Res"},{"key":"63335_CR11","doi-asserted-by":"publisher","first-page":"e94997","DOI":"10.1371\/journal.pone.0094997","volume":"9","author":"YW Hu","year":"2014","unstructured":"Hu, Y. W. et al. An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS One 9, e94997, https:\/\/doi.org\/10.1371\/journal.pone.0094997 (2014).","journal-title":"PLoS One"},{"key":"63335_CR12","doi-asserted-by":"publisher","first-page":"101042831773772","DOI":"10.1177\/1010428317737729","volume":"39","author":"Q He","year":"2017","unstructured":"He, Q. et al. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice. Tumour Biol 39, 1010428317737729, https:\/\/doi.org\/10.1177\/1010428317737729 (2017).","journal-title":"Tumour Biol"},{"key":"63335_CR13","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1101\/gad.1942110","volume":"24","author":"D Yu","year":"2010","unstructured":"Yu, D. et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev 24, 1620\u20131633, https:\/\/doi.org\/10.1101\/gad.1942110 (2010).","journal-title":"Genes Dev"},{"key":"63335_CR14","doi-asserted-by":"publisher","first-page":"G266","DOI":"10.1152\/ajpgi.90583.2008","volume":"296","author":"T Eismann","year":"2009","unstructured":"Eismann, T. et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol 296, G266\u2013274, https:\/\/doi.org\/10.1152\/ajpgi.90583.2008 (2009).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"63335_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408, https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"63335_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35314-6","volume":"8","author":"Q He","year":"2018","unstructured":"He, Q. et al. Loss of miR-144 signaling interrupts extracellular matrix remodeling after myocardial infarction leading to worsened cardiac function. Sci Rep 8, 16886, https:\/\/doi.org\/10.1038\/s41598-018-35314-6 (2018).","journal-title":"Sci Rep"},{"key":"63335_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/cvr\/cvt117","volume":"99","author":"PS Thiagarajan","year":"2013","unstructured":"Thiagarajan, P. S. et al. Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. Cardiovasc Res 99, 494\u2013504, https:\/\/doi.org\/10.1093\/cvr\/cvt117 (2013).","journal-title":"Cardiovasc Res"},{"key":"63335_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cvr\/cvs096","volume":"94","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Loss of the miR-144\/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94, 379\u2013390, https:\/\/doi.org\/10.1093\/cvr\/cvs096 (2012).","journal-title":"Cardiovasc Res"},{"key":"63335_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-018-0694-x","volume":"113","author":"J Li","year":"2018","unstructured":"Li, J. et al. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction. Basic Res Cardiol 113, 36, https:\/\/doi.org\/10.1007\/s00395-018-0694-x (2018).","journal-title":"Basic Res Cardiol"},{"key":"63335_CR20","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.4049\/jimmunol.1700473","volume":"199","author":"FJ Li","year":"2017","unstructured":"Li, F. J. et al. Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis. J Immunol 199, 1596\u20131605, https:\/\/doi.org\/10.4049\/jimmunol.1700473 (2017).","journal-title":"J Immunol"},{"key":"63335_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ncb898","volume":"5","author":"N Mor-Vaknin","year":"2003","unstructured":"Mor-Vaknin, N., Punturieri, A., Sitwala, K. & Markovitz, D. M. Vimentin is secreted by activated macrophages. Nat Cell Biol 5, 59\u201363, https:\/\/doi.org\/10.1038\/ncb898 (2003).","journal-title":"Nat Cell Biol"},{"key":"63335_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/bj3610461","volume":"361","author":"C Wang","year":"2002","unstructured":"Wang, C., JeBailey, L. & Ridgway, N. D. Oxysterol-binding-protein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments. Biochem J 361, 461\u2013472 (2002).","journal-title":"Biochem J"},{"key":"63335_CR23","doi-asserted-by":"publisher","first-page":"e42417","DOI":"10.1371\/journal.pone.0042417","volume":"7","author":"S Samanta","year":"2012","unstructured":"Samanta, S. et al. Characterization of a human 12\/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein. PLoS One 7, e42417, https:\/\/doi.org\/10.1371\/journal.pone.0042417 (2012).","journal-title":"PLoS One"},{"key":"63335_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34659-2","volume":"8","author":"L Haversen","year":"2018","unstructured":"Haversen, L. et al. Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice. Sci Rep 8, 16973, https:\/\/doi.org\/10.1038\/s41598-018-34659-2 (2018).","journal-title":"Sci Rep"},{"key":"63335_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/ATVBAHA.117.309918","volume":"38","author":"P Doddapattar","year":"2018","unstructured":"Doddapattar, P. et al. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Arterioscler Thromb Vasc Biol 38, 520\u2013528, https:\/\/doi.org\/10.1161\/ATVBAHA.117.309918 (2018).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"63335_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood.V98.5.1424","volume":"98","author":"N Methia","year":"2001","unstructured":"Methia, N., Andre, P., Denis, C. V., Economopoulos, M. & Wagner, D. D. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 98, 1424\u20131428 (2001).","journal-title":"Blood"},{"key":"63335_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6.5.11947","volume":"6","author":"M Taneike","year":"2010","unstructured":"Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600\u2013606, https:\/\/doi.org\/10.4161\/auto.6.5.11947 (2010).","journal-title":"Autophagy"},{"key":"63335_CR28","doi-asserted-by":"publisher","first-page":"15966","DOI":"10.18632\/oncotarget.3862","volume":"6","author":"CY Liu","year":"2015","unstructured":"Liu, C. Y., Lin, H. H., Tang, M. J. & Wang, Y. K. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget 6, 15966\u201315983, https:\/\/doi.org\/10.18632\/oncotarget.3862 (2015).","journal-title":"Oncotarget"},{"key":"63335_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11853","volume":"7","author":"SM Evrard","year":"2016","unstructured":"Evrard, S. M. et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun 7, 11853, https:\/\/doi.org\/10.1038\/ncomms11853 (2016).","journal-title":"Nat Commun"},{"key":"63335_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/nnm.11.185","volume":"7","author":"EM Plummer","year":"2012","unstructured":"Plummer, E. M., Thomas, D., Destito, G., Shriver, L. P. & Manchester, M. Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions. Nanomedicine (Lond) 7, 877\u2013888, https:\/\/doi.org\/10.2217\/nnm.11.185 (2012).","journal-title":"Nanomedicine (Lond)"},{"key":"63335_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2015.04.009","volume":"240","author":"K Ozturk","year":"2015","unstructured":"Ozturk, K. et al. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. Atherosclerosis 240, 380\u2013386, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.009 (2015).","journal-title":"Atherosclerosis"},{"key":"63335_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12944-015-0141-z","volume":"14","author":"X Xu","year":"2015","unstructured":"Xu, X. et al. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis 14, 158, https:\/\/doi.org\/10.1186\/s12944-015-0141-z (2015).","journal-title":"Lipids Health Dis"},{"key":"63335_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.ATV.19.8.1938","volume":"19","author":"AH Lichtman","year":"1999","unstructured":"Lichtman, A. H. et al. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 19, 1938\u20131944 (1999).","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63335-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63335-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:16:26Z","timestamp":1670318186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63335-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63335-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6127"}}